Reduction of urinary thiols in nephrotic syndrome - A possible effect of free iron

Indrajit Sinha, Sandip Ghosh, Prasenjit Dey, Jose Jacob, Dibyajyoti Banerjee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Albumin is a potent antioxidant as it chelates transitional metals and contains antioxidants like thiol and bilirubin. In neprotic syndrome, the defining parameter is proteinuria with hypoalbuminemia. Therefore albuminuria in nephrotic syndrome may increase toxic transitional metal ions and also can cause loss of albumin associated antioxidants causing oxidative stress to the individual. Methods: We investigated this possibility and estimated some markers of oxidative stress in 20 nephrotic syndrome patients and healthy controls along with urinary thiols, urinary bilirubin and plasma free iron in both cases and in the controls. Result: We found oxidative stress in 20 nephrotic syndrome patients and the markers of oxidative stress correlated significantly with proteinuria, but the urine of nephrotic syndrome patients (28.33±4.2 μmol/g creatinine)contained significantly less thiols compared to the healthy controls (88.45±10.6 μmol/g creatinine) and no biliribin. The patients plasma also showed free iron (0.7±0.05 μmol/l), a parameter undetectable in the healthy controls. Conclusion: We suggest that oxidative stress and presence of free iron in the patients were responsible for less thioluria and no bilirubinuria. A detailed study of oxidative biology in a large cohort of nephrotic syndrome patients is necessary to confirm the presence of free iron as appropriate chelation of free iron may benefit the long-term prognosis of the disease.

Original languageEnglish
Pages (from-to)91-96
Number of pages6
JournalClinica Chimica Acta
Volume355
Issue number1-2
DOIs
Publication statusPublished - 01-01-2005
Externally publishedYes

Fingerprint

Oxidative stress
Nephrotic Syndrome
Sulfhydryl Compounds
Iron
Oxidative Stress
ferrous sulfate
Antioxidants
Bilirubin
Albumins
Creatinine
Proteinuria
Plasmas
Metals
Poisons
Hypoalbuminemia
Chelation
Albuminuria
Metal ions
Urine
Ions

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Sinha, Indrajit ; Ghosh, Sandip ; Dey, Prasenjit ; Jacob, Jose ; Banerjee, Dibyajyoti. / Reduction of urinary thiols in nephrotic syndrome - A possible effect of free iron. In: Clinica Chimica Acta. 2005 ; Vol. 355, No. 1-2. pp. 91-96.
@article{6f8dd174b4834e23b2675340d020c700,
title = "Reduction of urinary thiols in nephrotic syndrome - A possible effect of free iron",
abstract = "Background: Albumin is a potent antioxidant as it chelates transitional metals and contains antioxidants like thiol and bilirubin. In neprotic syndrome, the defining parameter is proteinuria with hypoalbuminemia. Therefore albuminuria in nephrotic syndrome may increase toxic transitional metal ions and also can cause loss of albumin associated antioxidants causing oxidative stress to the individual. Methods: We investigated this possibility and estimated some markers of oxidative stress in 20 nephrotic syndrome patients and healthy controls along with urinary thiols, urinary bilirubin and plasma free iron in both cases and in the controls. Result: We found oxidative stress in 20 nephrotic syndrome patients and the markers of oxidative stress correlated significantly with proteinuria, but the urine of nephrotic syndrome patients (28.33±4.2 μmol/g creatinine)contained significantly less thiols compared to the healthy controls (88.45±10.6 μmol/g creatinine) and no biliribin. The patients plasma also showed free iron (0.7±0.05 μmol/l), a parameter undetectable in the healthy controls. Conclusion: We suggest that oxidative stress and presence of free iron in the patients were responsible for less thioluria and no bilirubinuria. A detailed study of oxidative biology in a large cohort of nephrotic syndrome patients is necessary to confirm the presence of free iron as appropriate chelation of free iron may benefit the long-term prognosis of the disease.",
author = "Indrajit Sinha and Sandip Ghosh and Prasenjit Dey and Jose Jacob and Dibyajyoti Banerjee",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.cccn.2004.12.011",
language = "English",
volume = "355",
pages = "91--96",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

Reduction of urinary thiols in nephrotic syndrome - A possible effect of free iron. / Sinha, Indrajit; Ghosh, Sandip; Dey, Prasenjit; Jacob, Jose; Banerjee, Dibyajyoti.

In: Clinica Chimica Acta, Vol. 355, No. 1-2, 01.01.2005, p. 91-96.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduction of urinary thiols in nephrotic syndrome - A possible effect of free iron

AU - Sinha, Indrajit

AU - Ghosh, Sandip

AU - Dey, Prasenjit

AU - Jacob, Jose

AU - Banerjee, Dibyajyoti

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Background: Albumin is a potent antioxidant as it chelates transitional metals and contains antioxidants like thiol and bilirubin. In neprotic syndrome, the defining parameter is proteinuria with hypoalbuminemia. Therefore albuminuria in nephrotic syndrome may increase toxic transitional metal ions and also can cause loss of albumin associated antioxidants causing oxidative stress to the individual. Methods: We investigated this possibility and estimated some markers of oxidative stress in 20 nephrotic syndrome patients and healthy controls along with urinary thiols, urinary bilirubin and plasma free iron in both cases and in the controls. Result: We found oxidative stress in 20 nephrotic syndrome patients and the markers of oxidative stress correlated significantly with proteinuria, but the urine of nephrotic syndrome patients (28.33±4.2 μmol/g creatinine)contained significantly less thiols compared to the healthy controls (88.45±10.6 μmol/g creatinine) and no biliribin. The patients plasma also showed free iron (0.7±0.05 μmol/l), a parameter undetectable in the healthy controls. Conclusion: We suggest that oxidative stress and presence of free iron in the patients were responsible for less thioluria and no bilirubinuria. A detailed study of oxidative biology in a large cohort of nephrotic syndrome patients is necessary to confirm the presence of free iron as appropriate chelation of free iron may benefit the long-term prognosis of the disease.

AB - Background: Albumin is a potent antioxidant as it chelates transitional metals and contains antioxidants like thiol and bilirubin. In neprotic syndrome, the defining parameter is proteinuria with hypoalbuminemia. Therefore albuminuria in nephrotic syndrome may increase toxic transitional metal ions and also can cause loss of albumin associated antioxidants causing oxidative stress to the individual. Methods: We investigated this possibility and estimated some markers of oxidative stress in 20 nephrotic syndrome patients and healthy controls along with urinary thiols, urinary bilirubin and plasma free iron in both cases and in the controls. Result: We found oxidative stress in 20 nephrotic syndrome patients and the markers of oxidative stress correlated significantly with proteinuria, but the urine of nephrotic syndrome patients (28.33±4.2 μmol/g creatinine)contained significantly less thiols compared to the healthy controls (88.45±10.6 μmol/g creatinine) and no biliribin. The patients plasma also showed free iron (0.7±0.05 μmol/l), a parameter undetectable in the healthy controls. Conclusion: We suggest that oxidative stress and presence of free iron in the patients were responsible for less thioluria and no bilirubinuria. A detailed study of oxidative biology in a large cohort of nephrotic syndrome patients is necessary to confirm the presence of free iron as appropriate chelation of free iron may benefit the long-term prognosis of the disease.

UR - http://www.scopus.com/inward/record.url?scp=17044395544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17044395544&partnerID=8YFLogxK

U2 - 10.1016/j.cccn.2004.12.011

DO - 10.1016/j.cccn.2004.12.011

M3 - Article

VL - 355

SP - 91

EP - 96

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -